Women Treated for DCIS Live Longer Than Women With No History of DCIS

Results from a study presented at the recently held European Cancer Congress suggest that women treated for ductal carcinoma in situ (DCIS) actually live longer than women who haven’t been diagnosed with DCIS. Overall, women treated for DCIS had a 10% lower risk of dying from any cause compared to women with no history of the disease. The women who had been diagnosed with DCIS did have a higher risk of dying from breast cancer, but a lower risk of dying from most other conditions and other cancers.